Medisapiens Ltd.

MediSapiens and Bayer HealthCare to Develop Platform for Managing and Analyzing Genomics Data

Transcriptome Viewer - Comprehensive Genome-wide Map of Human Gene Expression Activity Released for Public by MediSapiens

MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software

HELSINKI, October 11, 2011 - MediSapiens Ltd and Bayer HealthCare Pharmaceuticals have agreed to develop a platform for genomics data management and analysis in Oncology.

MORE..

HELSINKI, Finland, September 29, 2011 - MediSapiens Ltd, a Finnish bioinformatics company, has released the most comprehensive map of human gene expression yet for public use.

MORE..

Older News

HELSINKI, June 1, 2010 - MediSapiens, world's first software company for personalized cancer medicine in oncology clinics and drug development, completed $ 1 million (EUR 0.8 million) seed round investment from Veraventure, ETFIII advised by Eqvitec Partners, VTT Ventures and Lifeline Ventures.

MORE..